CHF6467

· Chiesi Farmaceutici S.p.A.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CHF6467, covering 2022-02-23 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG) [Phase 2]